Projecting future drug expenditures - 2008

James M. Hoffman, Nilay D Shah, Lee C. Vermeulen, Fred Doloresco, Penny Grim, Robert J. Hunkler, Karrie M. Hontz, Glen T. Schumock

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Purpose. Drug expenditure trends in 2006 and 2007, projected drug expenditures by setting for 2008, and factors likely to influence drug expenditures are discussed. Summary. Various factors are likely to influence drug expenditures in 2008, including drugs in development, the diffusion of new drugs, drug safety concerns, generic drugs, Medicare Part D, and changes in the drug supply chain. The increasing availability of important generic drugs and drug safety concerns continue to moderate growth in drug expenditures. The drug supply chain remains dynamic and may influence drug expenditures, particularly in specialized therapeutic areas. Initial data suggest the Medicare Part D benefit has influenced drug expenditures, but the ultimate impact of the benefit on drug expenditures remains unclear. From 2005 to 2006, total drug expenditures increased by 8.7% to $275 billion. Drug expenditures in clinics continue to grow more rapidly than in other settings, with a 20.9% increase from 2005 to 2006, and drug expenditures in clinics are now greater than the amount spent in hospitals. Hospital drug expenditures increased at a moderate rate of only 3.8% from 2005 to 2006; through the first nine months of 2007, hospital drug expenditures increased by only 2.2% compared with the same period in 2006. Conclusion. In 2008, we project a 5-7% increase in drug expenditures in outpatient settings, a 12-14% increase in clinics, and a 4-6% increase in hospitals.

Original languageEnglish (US)
Pages (from-to)234-253
Number of pages20
JournalAmerican Journal of Health-System Pharmacy
Volume65
Issue number3
DOIs
StatePublished - Feb 1 2008

Fingerprint

Health Expenditures
Pharmaceutical Preparations
Medicare Part D
Generic Drugs
Safety

Keywords

  • Costs
  • Drugs
  • Economics
  • Health-benefit programs
  • Prescriptions
  • United States

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Leadership and Management
  • Medicine(all)

Cite this

Hoffman, J. M., Shah, N. D., Vermeulen, L. C., Doloresco, F., Grim, P., Hunkler, R. J., ... Schumock, G. T. (2008). Projecting future drug expenditures - 2008. American Journal of Health-System Pharmacy, 65(3), 234-253. https://doi.org/10.2146/ajhp070629

Projecting future drug expenditures - 2008. / Hoffman, James M.; Shah, Nilay D; Vermeulen, Lee C.; Doloresco, Fred; Grim, Penny; Hunkler, Robert J.; Hontz, Karrie M.; Schumock, Glen T.

In: American Journal of Health-System Pharmacy, Vol. 65, No. 3, 01.02.2008, p. 234-253.

Research output: Contribution to journalArticle

Hoffman, JM, Shah, ND, Vermeulen, LC, Doloresco, F, Grim, P, Hunkler, RJ, Hontz, KM & Schumock, GT 2008, 'Projecting future drug expenditures - 2008', American Journal of Health-System Pharmacy, vol. 65, no. 3, pp. 234-253. https://doi.org/10.2146/ajhp070629
Hoffman JM, Shah ND, Vermeulen LC, Doloresco F, Grim P, Hunkler RJ et al. Projecting future drug expenditures - 2008. American Journal of Health-System Pharmacy. 2008 Feb 1;65(3):234-253. https://doi.org/10.2146/ajhp070629
Hoffman, James M. ; Shah, Nilay D ; Vermeulen, Lee C. ; Doloresco, Fred ; Grim, Penny ; Hunkler, Robert J. ; Hontz, Karrie M. ; Schumock, Glen T. / Projecting future drug expenditures - 2008. In: American Journal of Health-System Pharmacy. 2008 ; Vol. 65, No. 3. pp. 234-253.
@article{c8301268c9f547bfbb8ff8798d939616,
title = "Projecting future drug expenditures - 2008",
abstract = "Purpose. Drug expenditure trends in 2006 and 2007, projected drug expenditures by setting for 2008, and factors likely to influence drug expenditures are discussed. Summary. Various factors are likely to influence drug expenditures in 2008, including drugs in development, the diffusion of new drugs, drug safety concerns, generic drugs, Medicare Part D, and changes in the drug supply chain. The increasing availability of important generic drugs and drug safety concerns continue to moderate growth in drug expenditures. The drug supply chain remains dynamic and may influence drug expenditures, particularly in specialized therapeutic areas. Initial data suggest the Medicare Part D benefit has influenced drug expenditures, but the ultimate impact of the benefit on drug expenditures remains unclear. From 2005 to 2006, total drug expenditures increased by 8.7{\%} to $275 billion. Drug expenditures in clinics continue to grow more rapidly than in other settings, with a 20.9{\%} increase from 2005 to 2006, and drug expenditures in clinics are now greater than the amount spent in hospitals. Hospital drug expenditures increased at a moderate rate of only 3.8{\%} from 2005 to 2006; through the first nine months of 2007, hospital drug expenditures increased by only 2.2{\%} compared with the same period in 2006. Conclusion. In 2008, we project a 5-7{\%} increase in drug expenditures in outpatient settings, a 12-14{\%} increase in clinics, and a 4-6{\%} increase in hospitals.",
keywords = "Costs, Drugs, Economics, Health-benefit programs, Prescriptions, United States",
author = "Hoffman, {James M.} and Shah, {Nilay D} and Vermeulen, {Lee C.} and Fred Doloresco and Penny Grim and Hunkler, {Robert J.} and Hontz, {Karrie M.} and Schumock, {Glen T.}",
year = "2008",
month = "2",
day = "1",
doi = "10.2146/ajhp070629",
language = "English (US)",
volume = "65",
pages = "234--253",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "3",

}

TY - JOUR

T1 - Projecting future drug expenditures - 2008

AU - Hoffman, James M.

AU - Shah, Nilay D

AU - Vermeulen, Lee C.

AU - Doloresco, Fred

AU - Grim, Penny

AU - Hunkler, Robert J.

AU - Hontz, Karrie M.

AU - Schumock, Glen T.

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Purpose. Drug expenditure trends in 2006 and 2007, projected drug expenditures by setting for 2008, and factors likely to influence drug expenditures are discussed. Summary. Various factors are likely to influence drug expenditures in 2008, including drugs in development, the diffusion of new drugs, drug safety concerns, generic drugs, Medicare Part D, and changes in the drug supply chain. The increasing availability of important generic drugs and drug safety concerns continue to moderate growth in drug expenditures. The drug supply chain remains dynamic and may influence drug expenditures, particularly in specialized therapeutic areas. Initial data suggest the Medicare Part D benefit has influenced drug expenditures, but the ultimate impact of the benefit on drug expenditures remains unclear. From 2005 to 2006, total drug expenditures increased by 8.7% to $275 billion. Drug expenditures in clinics continue to grow more rapidly than in other settings, with a 20.9% increase from 2005 to 2006, and drug expenditures in clinics are now greater than the amount spent in hospitals. Hospital drug expenditures increased at a moderate rate of only 3.8% from 2005 to 2006; through the first nine months of 2007, hospital drug expenditures increased by only 2.2% compared with the same period in 2006. Conclusion. In 2008, we project a 5-7% increase in drug expenditures in outpatient settings, a 12-14% increase in clinics, and a 4-6% increase in hospitals.

AB - Purpose. Drug expenditure trends in 2006 and 2007, projected drug expenditures by setting for 2008, and factors likely to influence drug expenditures are discussed. Summary. Various factors are likely to influence drug expenditures in 2008, including drugs in development, the diffusion of new drugs, drug safety concerns, generic drugs, Medicare Part D, and changes in the drug supply chain. The increasing availability of important generic drugs and drug safety concerns continue to moderate growth in drug expenditures. The drug supply chain remains dynamic and may influence drug expenditures, particularly in specialized therapeutic areas. Initial data suggest the Medicare Part D benefit has influenced drug expenditures, but the ultimate impact of the benefit on drug expenditures remains unclear. From 2005 to 2006, total drug expenditures increased by 8.7% to $275 billion. Drug expenditures in clinics continue to grow more rapidly than in other settings, with a 20.9% increase from 2005 to 2006, and drug expenditures in clinics are now greater than the amount spent in hospitals. Hospital drug expenditures increased at a moderate rate of only 3.8% from 2005 to 2006; through the first nine months of 2007, hospital drug expenditures increased by only 2.2% compared with the same period in 2006. Conclusion. In 2008, we project a 5-7% increase in drug expenditures in outpatient settings, a 12-14% increase in clinics, and a 4-6% increase in hospitals.

KW - Costs

KW - Drugs

KW - Economics

KW - Health-benefit programs

KW - Prescriptions

KW - United States

UR - http://www.scopus.com/inward/record.url?scp=38749149250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38749149250&partnerID=8YFLogxK

U2 - 10.2146/ajhp070629

DO - 10.2146/ajhp070629

M3 - Article

C2 - 18216009

AN - SCOPUS:38749149250

VL - 65

SP - 234

EP - 253

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 3

ER -